NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Company Directory Search

Propella Therapeutics Inc.

Propella Therapeutics Inc.

Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer.

Company Location

120 Mosaic Blvd., Suite 130-3

Pittsboro
NC
27312
Phone
(855) 225-6378
Region

Company Details

Year founded
2020
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
PRL-02 (Abiraterone Decanoate) for the treatment of metastatic prostate cancer; CGS-200-5 for osteoarthritis pain